After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Alembic Pharma osteoarthritis drug gets USFDA okay Ruchika Sharma1 Dec 2022 5:45 PM ISTDiclofenac Sodium Topical Solution is indicated for the treatment of the pain of osteoarthritis of the knee(s).
Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics Ruchika Sharma1 Dec 2022 4:33 PM ISTBengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...
Glenmark Pharma gets USFDA nod for generic version of Buphenyl tablets Ruchika Sharma3 Nov 2022 11:15 AM ISTBUPHENYL is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of...
US FDA approves Tepezza- first treatment for thyroid eye disease MD Bureau22 Jan 2020 10:32 AM ISTUS : The U.S. Food and Drug Administration (FDA) has given its nod to Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye...
